Finance

Lists
Why is ACIU up 9,42%?
Dive Deeper
ACIU:NASDAQ
AC Immune AG
US$2,44
+9,42%
(+0,21) 1D
US$2,40
-1,64% (-0,040)
After hours
Closed: 9 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACIU...
Open
US$2,32
High
US$2,55
Low
US$2,17
Mkt. cap
248,33 ລ້ານ
Avg. vol.
211,42 ພັນ
Volume
469,49 ພັນ
52-wk high
US$3,90
52-wk low
US$2,02
EPS
US$-0,53
Beta
1,64
Shares outstanding
101,77 ລ້ານ
No. of employees
106
Open
US$2,32
High
US$2,55
Low
US$2,17
Mkt. cap
248,33 ລ້ານ
Avg. vol.
211,42 ພັນ
Volume
469,49 ພັນ
52-wk high
US$3,90
52-wk low
US$2,02
EPS
US$-0,53
Beta
1,64
Shares outstanding
101,77 ລ້ານ
No. of employees
106
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
3 ຊົ່ວໂມງກ່ອນ
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
Investing.com
Investing.com
·
4 ຊົ່ວໂມງກ່ອນ
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
ChartMill
ChartMill
·
6 ຊົ່ວໂມງກ່ອນ
Most-Active S&P 500 Stocks in Today's Session
StoneX
StoneX
·
9 ຊົ່ວໂມງກ່ອນ
S&P 500 Forecast: SPX rises despite Nvidia’s decline
About AC Immune AG
CEOAndrea Pfeifer
Employees106
Founded2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ACIU in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACIU in the last 3 months.
Highest
Current US$2,44
US$12,00 (+391,80%)
Average
US$9,67 (+296,31%)
Lowest
US$8,00 (+227,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
US$9,00
+268,9%
11/05/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
US$12,00
+391,8%
11/05/2026
Thomas Shrader
BTIG
Buy
Maintained
US$8,00
+227,9%
11/04/2026
Marc Goodman
Leerink Partners
Buy
Maintained
-
-
04/07/2026
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
ກ.ຍ. 2026
Revenue
338,00 ພັນ
1,12 ລ້ານ
15,11 ລ້ານ
3,24 ລ້ານ
Cost of goods sold
10,62 ລ້ານ
11,74 ລ້ານ
10,48 ລ້ານ
-
Cost of revenue
10,62 ລ້ານ
11,74 ລ້ານ
10,48 ລ້ານ
-
Research and development expenses
-
-
-
9,85 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,19 ລ້ານ
4,17 ລ້ານ
3,54 ລ້ານ
3,52 ລ້ານ
Operating expense
4,12 ລ້ານ
4,16 ລ້ານ
3,44 ລ້ານ
13,04 ລ້ານ
Total operating expenses
14,74 ລ້ານ
15,91 ລ້ານ
13,92 ລ້ານ
13,04 ລ້ານ
Operating income
-14,41 ລ້ານ
-14,79 ລ້ານ
1,19 ລ້ານ
-9,80 ລ້ານ
Other non operating income
-
-
-
280,00 ພັນ
EBT including unusual items
-14,37 ລ້ານ
-14,80 ລ້ານ
1,87 ລ້ານ
-8,75 ລ້ານ
EBT excluding unusual items
-14,38 ລ້ານ
-14,80 ລ້ານ
1,87 ລ້ານ
-8,75 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-73,00 ພັນ
-11,00 ພັນ
-96,00 ພັນ
-330,00 ພັນ
Net income
-14,37 ລ້ານ
-14,80 ລ້ານ
1,87 ລ້ານ
-8,75 ລ້ານ
Net profit margin
-4.252,37%
-1.322,70%
12,40%
-269,73%
Earnings per share
-0,14
-0,15
0,02
-0,13
Interest and investment income
353,00 ພັນ
228,00 ພັນ
171,00 ພັນ
-
Interest expense
-42,00 ພັນ
-65,00 ພັນ
-61,00 ພັນ
-59,00 ພັນ
Net interest expenses
311,00 ພັນ
163,00 ພັນ
110,00 ພັນ
-59,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,08 ລ້ານ
-14,44 ລ້ານ
1,47 ລ້ານ
-9,45 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google